Neutrogena Pledges Postpartum Care Funding After Panettiere Death Fuels Boycott

Key points

• Neutrogena acknowledged it made Panettiere feel unsupported during a difficult time, stating, 'This is not what Neutrogena stands for or who we want to be.'
• The company committed to a 'significant investment' in an unnamed community health partner to improve women’s access to postpartum depression care, with details to follow.
• Panettiere, who died at 36 in Greenville, South Carolina, had served as a Neutrogena ambassador for a decade before the brand declined to renew her contract in 2015.
• Her 2026 memoir, 'This Is Me: A Reckoning,' detailed how Neutrogena cited a morality clause to end the partnership after she publicly discussed postpartum depression on a talk show.
• Social media users launched a boycott campaign, criticizing the brand for selling products to women while allegedly undermining their health and well-being.

Background

This controversy resurfaced after Panettiere’s sudden death on August 17, 2026. While earlier archive entries noted the initial backlash and the DEA’s involvement in the investigation, the current focus is on the brand’s official response. The incident highlights broader societal issues regarding maternal mental health, with experts noting that postpartum depression affects up to 1 in 5 new mothers in the U.S. and is a leading cause of maternal death. The backlash also coincided with increased public awareness of workplace accommodations for new mothers, as highlighted by USA Today’s coverage of the topic.

How outlets are covering it

The Hollywood Reporter and ABC News focused on Neutrogena’s official statement and the immediate social media reaction, emphasizing the brand’s admission of failure. TheWrap highlighted the specific timeline of events, noting Panettiere’s 2015 appearance on 'Live With Kelly and Michael' as the catalyst for the contract non-renewal. USA Today provided a broader public health perspective, using Panettiere’s story to discuss the stigma and workplace challenges surrounding postpartum depression, featuring voices from medical professionals and affected mothers. All sources agree on the core facts of the brand’s response and the cause of the backlash, but differ in emphasis: entertainment outlets focused on the celebrity-brand dynamic, while USA Today framed it as a public health crisis.

Why it matters

This case illustrates the growing power of social media to hold corporations accountable for past actions, particularly regarding sensitive health issues. It also underscores the ongoing need for better workplace and societal support for maternal mental health, moving beyond policy to cultural change. The incident may influence how brands approach partnerships with public figures and how they handle disclosures of mental health struggles.

What to watch

Neutrogena has promised to share more details about its investment in a community health partner once plans are finalized. The investigation into Panettiere’s death continues, with the DEA involved, though no foul play has been reported. Public discourse may continue to focus on workplace accommodations for postpartum depression and corporate responsibility in mental health advocacy.